Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects | Neuropsychopharmacology
Frontiers | Treatment of a Complex Personality Disorder Using Repeated Doses of LSD—A Case Report on Significant Improvements in the Absence of Acute Drug Effects | Psychiatry
Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects | Neuropsychopharmacology
Genetic influence of CYP2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis | Scientific Reports
LSD flattens the brain's energy landscape: evidence from receptor-informed network control theory | bioRxiv
Volcano Watch — Oceans on an acid trip are cause for concern | U.S. Geological Survey
Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects | Neuropsychopharmacology
Ever Had a Really Long Acid Trip? Now Science Knows Why | WIRED
/what-does-it-feel-like-to-get-high-on-acid-21886-v1-5c0192cfc9e77c00017275e7.png "Understanding the Acid Trip Experience")
Understanding the Acid Trip Experience
Modern Clinical Research on LSD | Neuropsychopharmacology
LSD alters dynamic integration and segregation in the human brain - ScienceDirect
Thinking of using LSD for the first time? Here are some things to think about | Global Drug Survey
There is no hiding with LSD | Sue Blackmore | The Guardian
Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects | Neuropsychopharmacology
Is LSD Safe - Latest Research Findings - Drug Science
Crystal Structure of an LSD-Bound Human Serotonin Receptor: Cell
Michael Pollan Drops Acid — and Comes Back From His Trip Convinced - The New York Times
Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1‐cyclopropanoyl‐d‐lysergic acid diethylamide (1CP‐LSD) - Brandt - 2020 - Drug Testing and Analysis - Wiley Online Library
The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial | SpringerLink
amine (IRL790), a Novel Dopamine Transmission Modulator for the Treatment of Motor and Psychiatric Complications in Parkinson Disease | Journal of Pharmacology and ...](https://jpet.aspetjournals.org/content/jpet/374/1/113/F4.large.jpg "Preclinical Pharmacology of [2-(3-Fluoro-5-Methanesulfonyl-phenoxy)Ethyl](Propyl)amine (IRL790), a Novel Dopamine Transmission Modulator for the Treatment of Motor and Psychiatric Complications in Parkinson Disease | Journal of Pharmacology and ...")
Preclinical Pharmacology of [2-(3-Fluoro-5-Methanesulfonyl-phenoxy)Ethyl](Propyl)amine (IRL790), a Novel Dopamine Transmission Modulator for the Treatment of Motor and Psychiatric Complications in Parkinson Disease | Journal of Pharmacology and ...
Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects | Neuropsychopharmacology
A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers - Johannes G Ramaekers, Nadia Hutten, Natasha L Mason, Patrick Dolder, Eef L Theunissen, Friederike Holze, Matthias E Liechti,
How bad trips on LSD and magic mushrooms compare | Drugs | The Guardian
This is your brain on LSD, literally | CNN
Erowid LSD (Acid) Vault : Effects
